GARP Dampens Cancer Immunity by Sustaining Function and Accumulation of Regulatory T Cells in the Colon.

Activated regulatory T (Treg) cells express the surface receptor glycoprotein-A repetitions predominant (GARP), which binds and activates latent TGFβ. How GARP modulates Treg function in inflammation and cancer remains unclear. Here we demonstrate that loss of GARP in Treg cells leads to spontaneous inflammation with highly activated CD4+ and CD8+ T cells and development of enteritis. Treg cells lacking GARP were unable to suppress pathogenic T-cell responses in multiple models of inflammation, including T-cell transfer colitis. GARP-/- Treg cells were significantly reduced in the gut and exhibited a reduction in CD103 expression, a colon-specific migratory marker. In the colitis-associated colon cancer model, GARP on Treg cells dampened immune surveillance, and mice with GARP-/- Treg cells exhibited improved antitumor immunity. Thus, GARP empowers the functionality of Treg cells and their tissue-specific accumulation, highlighting the importance of cell surface TGFβ in Treg function and GARP as a potential therapeutic target for colorectal cancer therapy.Significance: These findings uncover functions of membrane-bound TGFβ and GARP that tune the activity of Treg cells, highlighting a potential treatment strategy in autoimmune diseases and cancer.

[1]  S. Savvides,et al.  Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cells , 2018, Science.

[2]  M. Shlomchik,et al.  B lymphocytes confer immune tolerance via cell surface GARP-TGF-β complex. , 2018, JCI insight.

[3]  Zihai Li,et al.  Immunoregulatory functions and the therapeutic implications of GARP-TGF-β in inflammation and cancer , 2018, Journal of Hematology & Oncology.

[4]  S. Kaneko,et al.  Glycoprotein A repetitions predominant (GARP) positively regulates transforming growth factor (TGF) β3 and is essential for mouse palatogenesis , 2017, The Journal of Biological Chemistry.

[5]  Y. Saeys,et al.  TGFβR signalling controls CD103+CD11b+ dendritic cell development in the intestine , 2017, Nature Communications.

[6]  I. Sagap,et al.  Molecular Signatures of Human Regulatory T Cells in Colorectal Cancer and Polyps , 2017, Front. Immunol..

[7]  M. Hennig,et al.  Platelets subvert T cell immunity against cancer via GARP-TGFβ axis , 2017, Science Immunology.

[8]  P. Howe,et al.  Surface Expression of TGFβ Docking Receptor GARP Promotes Oncogenesis and Immune Tolerance in Breast Cancer. , 2016, Cancer research.

[9]  P. Dijke,et al.  Immunoregulation by members of the TGFβ superfamily , 2016, Nature Reviews Immunology.

[10]  N. Olsen,et al.  TGF-β–Induced Regulatory T Cells Directly Suppress B Cell Responses through a Noncytotoxic Mechanism , 2016, The Journal of Immunology.

[11]  M. Hattori,et al.  Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers , 2016, Nature Medicine.

[12]  Y. Belkaid,et al.  The GARP/Latent TGF‐β1 complex on Treg cells modulates the induction of peripherally derived Treg cells during oral tolerance , 2016, European Journal of Immunology.

[13]  A. Classen,et al.  Integrin αE(CD103) Is Involved in Regulatory T-Cell Function in Allergic Contact Hypersensitivity. , 2015, The Journal of investigative dermatology.

[14]  P. Delvenne,et al.  Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo , 2015, Science Translational Medicine.

[15]  C. Riccardi,et al.  Glucocorticoid-Induced Tumour Necrosis Factor Receptor-Related Protein: A Key Marker of Functional Regulatory T Cells , 2015, Journal of immunology research.

[16]  D. Vergani,et al.  Regulatory T-cells in autoimmune diseases: challenges, controversies and--yet--unanswered questions. , 2015, Autoimmunity reviews.

[17]  A. Gruber,et al.  Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer. , 2014, Cancer research.

[18]  H. Stahl,et al.  Soluble GARP has potent antiinflammatory and immunomodulatory impact on human CD4⁺ T cells. , 2013, Blood.

[19]  E. Shevach,et al.  Regulation of the Expression of GARP/Latent TGF-β1 Complexes on Mouse T Cells and Their Role in Regulatory T Cell and Th17 Differentiation , 2013, The Journal of Immunology.

[20]  D. Gray,et al.  ICOS controls Foxp3+ regulatory T-cell expansion, maintenance and IL-10 production during helminth infection , 2013, European journal of immunology.

[21]  F. Powrie,et al.  Dysregulated Hematopoietic Stem and Progenitor Cell Activity Promotes Interleukin-23-Driven Chronic Intestinal Inflammation , 2012, Immunity.

[22]  E. Elkord,et al.  Helios expression in FoxP3+ T regulatory cells , 2012, Expert opinion on biological therapy.

[23]  T. Malek,et al.  IL-2 Receptor Signaling Is Essential for the Development of Klrg1+ Terminally Differentiated T Regulatory Cells , 2012, The Journal of Immunology.

[24]  D. Sargent,et al.  Prognostic Impact of FoxP3+ Regulatory T Cells in Relation to CD8+ T Lymphocyte Density in Human Colon Carcinomas , 2012, PloS one.

[25]  Suzanne R. Thibodeaux,et al.  Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL‐17 producing T cells , 2012, Aging cell.

[26]  D. Tran.  TGF-β: the sword, the wand, and the shield of FOXP3(+) regulatory T cells. , 2012, Journal of molecular cell biology.

[27]  J. Ellwart,et al.  CD103 is a hallmark of tumor‐infiltrating regulatory T cells , 2011, International journal of cancer.

[28]  J. Rivera-Nieves,et al.  The chemokine receptor CCR9 is required for the T-cell-mediated regulation of chronic ileitis in mice. , 2011, Gastroenterology.

[29]  Richard A Flavell,et al.  Autocrine transforming growth factor-β1 promotes in vivo Th17 cell differentiation. , 2011, Immunity.

[30]  K. Helzlsouer,et al.  Natural history of celiac disease autoimmunity in a USA cohort followed since 1974 , 2010, Annals of medicine.

[31]  R. Morita,et al.  Smad2 and Smad3 Are Redundantly Essential for the TGF-β–Mediated Regulation of Regulatory T Plasticity and Th1 Development , 2010, The Journal of Immunology.

[32]  D. Unutmaz,et al.  Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells , 2009, Proceedings of the National Academy of Sciences.

[33]  E. Shevach,et al.  GARP (LRRC32) is essential for the surface expression of latent TGF-β on platelets and activated FOXP3+ regulatory T cells , 2009, Proceedings of the National Academy of Sciences.

[34]  Shimon Sakaguchi,et al.  Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation , 2008, Proceedings of the National Academy of Sciences.

[35]  A. Kulkarni,et al.  A critical function for TGF-β signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells , 2008, Nature Immunology.

[36]  Markus F Neurath,et al.  An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression , 2007, Nature Protocols.

[37]  Yong Zhao,et al.  Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice , 2007, Journal of leukocyte biology.

[38]  P. Lipsky,et al.  Deficient CD4+CD25high T Regulatory Cell Function in Patients with Active Systemic Lupus Erythematosus1 , 2007, The Journal of Immunology.

[39]  D. Fitzpatrick,et al.  Expression of CD103 identifies human regulatory T-cell subsets. , 2006, The Journal of allergy and clinical immunology.

[40]  A. Rudensky,et al.  TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells , 2005, The Journal of experimental medicine.

[41]  Li Li,et al.  Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.

[42]  F. Powrie,et al.  Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells1 , 2003, The Journal of Immunology.

[43]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[44]  R. Flavell,et al.  Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease , 2000 .

[45]  M. Sporn,et al.  Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[46]  T. Rème,et al.  Contrasting effect of transforming growth factor type beta 1 (TGF‐β1) on proliferation and interleukin‐2 receptor expression in activated and rapidly cycling immature (CD3−CD4−CD8−) thymocytes , 1993, Journal of cellular physiology.

[47]  J. Murray.  Natural history of celiac disease autoimmunity in a USA cohort followed since 1974 , 2011 .

[48]  A. Torgashina,et al.  Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus. , 2007, Advances in experimental medicine and biology.

[49]  H. Ochs,et al.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.

[50]  R. Flavell,et al.  Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. , 2000, Immunity.

[51]  D. Perazzo,et al.  [Systemic lupus erythematosus]. , 1955, Prensa medica argentina.